Ipamorelin
This price is for one box, with ten pieces per box
- only 37 left in stock
- 49 people are viewing this right now
- 287 people has purchased this in 7 days
Returns & Exchanges within 30 daysAny return for unsatisfied item(s) is available within 30 days
Money Back GuaranteeA full refund within one week upon receiving your return
3-Month WarrantyCovering any possible defect in materials and workmanship
Safety AssuranceOur products are strictly tested and quality assured
Ipamorelin Peptide
Ipamorelin is a synthetic peptide that is composed of five amino acids, otherwise known as a pentadecapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), formally classified as a Growth Hormone Secretagogue (GHS). Its name is derived from the intention of its development. Ipamorelin peptide was designed to act via ghrelin receptor binding. The ghrelin receptors on the pituitary gland (the gland naturally involved with growth hormone, or hGH synthesis) are also known as Growth Hormone Secretagogue receptors (GHS-R). Through its implied action, Ipamorelin may host the potential to trigger the GHS-Rs on the pituitary gland and potentially stimulate the release of growth hormone. (1)
Overview
Ipamorelin is the first synthetic GHS that appears highly selective and may have the potential to augment the production of hGH without affecting other pituitary hormones such as prolactin or adrenocorticotropic hormone (ACTH). The potential increase in hGH might promote lipolysis and insulin-like growth factor-1 (IGF-1) production synthesis. Consequently, IGF-1 may become a mediator of hGH’s anabolic actions, and thereby the peptide may act to increase cellular proliferation and bone and muscle anabolism. (1)
Chemical Makeup
Molecular Formula: C 38 H 49 N 9 O 5 Molecular Weight: 711.86 g/mol Other Known Titles: NNC 26-0161
Research and Clinical Studies
Ipamorelin Peptide and Selective Agonism
Based on one 1998 murine model-based research study, researchers suggested that Ipamorelin may release growth hormones from the pituitary cells. When Ipamorelin was presented to swine and pentobarbitone anesthetized rats, it reportedly exhibited release in growth hormones. Upon further observation, the researchers hypothesized that similar to other growth hormone (GH) stimulating peptides, Ipamorelin may be a growth receptor agonist stimulating GH release through potential affinity in growth hormone receptors. Moreover, the researchers commented t